Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Azatadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 8/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 2/20 | 1.00 |
| ▸ | DRD2 | P14416 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 2/20 | 1.00 |
| ▸ | HTR2C | P28335 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 2/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | PTAFR | P25105 | 8/20 | 0.72 |
| ▸ | SETD7 | Q8WTS6 | 2/20 | 0.69 |
| ▸ | FNTA | P49354 | 3/20 | 0.57 |
| ▸ | FNTB | P49356 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.55 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.55 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azatadine SCHEMBL29746602 | 1.00 | HRH1 (1.00) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| Azatadine SCHEMBL29363595 | 1.00 | HRH1 (1.00) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| Azatadine SCHEMBL6061443 | 0.99 | HRH1 (0.97) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| SCHEMBL9215889 | 0.94 | HRH1 (0.89) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| Cyproheptadine SCHEMBL5934940 | 0.91 | HRH1 (0.83) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| Azatadine SCHEMBL450675 | 0.89 | HRH1 (0.79) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| Azatadine SCHEMBL450674 | 0.89 | HRH1 (0.79) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| Azatadine SCHEMBL450676 | 0.89 | HRH1 (0.79) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| SCHEMBL13937027 | 0.86 | HRH1 (0.76) | HRH1CHRM2HTR1ACHRM1DRD2 | |
| SCHEMBL14007275 | 0.84 | PTAFR (0.76) | HRH1CHRM2HTR1ACHRM1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10771 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| EP-4247331-B1 | ORODISPERSIBLE POWDER COMPOSITION COMPRISING AN ANTIHISTAMINE COMPOUND | BIOPHARMA SYNERGIES S L (ES) | 2025-10-08 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| CN-119212681-A | Method for preparing 3-D printed pharmaceutical products | 百时美施贵宝公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| CN-114072132-B | Bionic tissue adhesive hydrogel patch and application thereof | 赛拉尔研究有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-1988008302-A1 | COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS | SUNSHINE ABRAHAM (US) | 1988-11-03 | — | — | WO | claimed |
| US-4749720-A | ANALGESICS AND ANTIHISTAMINES | ANALGESIC ASSOCIATES (US) | 1988-06-07 | — | — | US | claimed |
| US-4749697-A | ADMINISTERING MIXTURES OF PIROXICAM, SUDOXICAM, OR ISOXICAM WITH ANTIHISTAMINE | ANALGESIC ASSOCIATES (US) | 1988-06-07 | — | — | US | claimed |
| US-4749723-A | ADMINISTERING MEFENAMIC ACID, SODIUM MECLOFENAMATE OR SALT WITH ANTIHISTAMINE | ANALGESIC ASSOCIATES (US) | 1988-06-07 | — | — | US | claimed |
| US-4749700-A | NASAL ADMINISTRATION LOWER DOSAGE | NASTECH PHARMACEUTICAL CO, INC. (US) | 1988-06-07 | — | — | US | claimed |
| US-4619934-A | AND ANTIHISTAMINE, DECONGESTANT, ANTITUSSIVE OR EXPECTORANT | ANALGESIC ASSOCIATES (US) | 1986-10-28 | — | — | US | claimed |
| EP-0188538-A1 | TRANSDERMAL DELIVERY OF AZATADINE. | SCHERING CORP (US) | 1986-07-30 | — | — | EP | claimed |
| EP-0180597-A1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. | SUNSHINE ABRAHAM (US) | 1986-05-14 | — | — | EP | claimed |
| WO-1986000806-A1 | TRANSDERMAL DELIVERY OF AZATADINE | SCHERING CORPORATION (US) | 1986-02-13 | — | — | WO | claimed |
| WO-1985004589-A1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | SUNSHINE ABRAHAM | 1985-10-24 | — | — | WO | claimed |